Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05716802 |
Other study ID # |
xmh123 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
July 7, 2020 |
Est. completion date |
July 12, 2022 |
Study information
Verified date |
March 2024 |
Source |
Hebei Province Veterans Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Fractures are common accidents for long-term hospitalized patients with schizophrenia (SZ) in
psychiatric hospitals, and once they occur, patients usually endure the pain of fractures for
a long time. Accumulating evidence has supported implementing dance/movement therapy (DMT) as
a promising intervention for patients with SZ. However, no study has been conducted to
investigate its role in balance ability and metabolic parameters in SZ. This study was
designed to investigate the treatment outcome of a 12-week DMT intervention on bone mineral
density, balance ability, and metabolic profile in patients with SZ using a randomized,
controlled trial design.
Description:
Schizophrenia (SZ) is a chronic, severe psychiatric disorder that affects approximately 1% of
the population. The psychiatric symptoms and high rate of relapse of SZ can significantly
impair cognitive and social functioning, including problem-solving skills, interpersonal
relationships, and work performance. Moreover, individuals with SZ usually have higher
disability and premature mortality rates compared to the general population. Falls are a
common concern in hospital settings, with studies reporting a fall rate between three and
five falls per 1000 bed days. Osteoporosis and its precursors, e.g. osteopenia and low bone
mineral density (BMD), have been reported in chronic patients with SZ and were strong
predictors for subsequent falls and fractures in psychiatric hospitals.
Dance/movement therapy (DMT), as one of the creative arts therapies, is an emerging therapy
for the rehabilitation of patients with SZ in recent years. DMT therapy uses dance activities
and body movements to enhance well-being, mood, and quality of life. DMT therapy uses
movement, dance, and interpersonal communication to explore a person's emotional, cognitive,
social, and physical integration, enabling patients to enhance self-expression, accept and
reconnect with their bodies, and strengthen their fitness. The patients share their emotions,
concerns, and coping strategies with others through dance/movement. It can be applied to
individuals of all ages, races, and genders and can be efficacious in individuals who
experience losses in social, physical, and psychological functions. DMT has also been used to
improve the cognition and social function of patients with mental diseases in psychiatric
hospitals. In particular, a few studies have reported a critical role of DMT intervention in
negative symptoms in chronic patients with SZ. However, there is still a lack of evidence
that whether DMT is an effective therapy to increase the mean bone mineral density and reduce
the risk of fractures due to falls in long-term hospitalized patients with SZ.
In the present study, the investigators hypothesized that DMT intervention was effective to
increase BMD and balance ability and decrease the metabolic parameters in long-term
hospitalized male veterans with SZ as compared to the control group. They also examined
whether DMT intervention can significantly change BMI, the levels of lipid profile, and serum
calcium in patients.